Magrolimab | Interleukin Related interleukin-related.com

Product Name :
Magrolimab

Search keywords :
Magrolimab

drugId :
null

Target Vo:
Cluster of differentiation 47

Target Vo Short Name :
CD47

Moa_Name:
Cluster of differentiation 47 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Stanford University

Active Company_Name :
Gilead Sciences Inc

Active Indication_Name:
Colorectal Neoplasms

In Active Indication_Name:
Lymphoma, Non-Hodgkin

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Alexa Fluor® 594-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) In stock
Phospho-p53 (Ser37) Rabbit pAb web
SIRT6 Antibody: SIRT6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to SIRT6. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts